CONMED Corporation
CNMD
$50.41
$0.591.18%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.70% | 129.09% | -50.41% | -94.16% | -28.54% |
| Total Depreciation and Amortization | 2.56% | 3.20% | 6.29% | 3.52% | 4.10% |
| Total Amortization of Deferred Charges | -24.06% | -11.57% | -3.69% | -11.57% | -1.28% |
| Total Other Non-Cash Items | -1.51% | -74.66% | 80.00% | 152.23% | 1,222.22% |
| Change in Net Operating Assets | 35.91% | -3,922.64% | 32.91% | 1,664.35% | -218.86% |
| Cash from Operations | 27.33% | -67.56% | 6.92% | 4.85% | -32.73% |
| Capital Expenditure | 48.79% | 23.47% | -26.51% | -51.71% | -59.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 301.89% | 240.25% | -76.01% | -51.71% | -59.58% |
| Total Debt Issued | 331.06% | 8.43% | 24.67% | 16.78% | -1.63% |
| Total Debt Repaid | -317.72% | 14.17% | -11.29% | -15.98% | 7.97% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -0.23% | -0.42% | -0.45% |
| Other Financing Activities | -123.23% | -38.09% | -25.71% | -25.01% | 21.67% |
| Cash from Financing | -74.29% | 20.58% | 26.83% | -12.09% | 39.83% |
| Foreign Exchange rate Adjustments | -108.21% | -199.39% | 101.52% | -96.90% | 354.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 248.26% | -152.49% | 113.48% | -47.97% | 68.91% |